|
Name |
(3S,6S)-3-[(R)-hydroxy-[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methyl]-6-methylpiperazine-2,5-dione
|
Molecular Formula | C19H23N3O3 | |
IUPAC Name* |
(3S,6S)-3-[(R)-hydroxy-[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methyl]-6-methylpiperazine-2,5-dione
|
|
SMILES |
C[C@H]1C(=O)N[C@H](C(=O)N1)[C@@H](C2=C(NC3=CC=CC=C32)C(C)(C)C=C)O
|
|
InChI |
InChI=1S/C19H23N3O3/c1-5-19(3,4)16-13(11-8-6-7-9-12(11)21-16)15(23)14-18(25)20-10(2)17(24)22-14/h5-10,14-15,21,23H,1H2,2-4H3,(H,20,25)(H,22,24)/t10-,14-,15+/m0/s1
|
|
InChIKey |
WWTLLWSFFUIRKA-NZVBXONLSA-N
|
|
Synonyms |
Rubrumline M
|
|
CAS | NA | |
PubChem CID | 156583107 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 341.4 | ALogp: | 2.6 |
HBD: | 4 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 94.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.643 |
Caco-2 Permeability: | -5.405 | MDCK Permeability: | 0.00001310 |
Pgp-inhibitor: | 0.53 | Pgp-substrate: | 0.189 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.02 |
Blood-Brain-Barrier Penetration (BBB): | 0.645 | Plasma Protein Binding (PPB): | 80.97% |
Volume Distribution (VD): | 1.394 | Fu: | 23.66% |
CYP1A2-inhibitor: | 0.31 | CYP1A2-substrate: | 0.212 |
CYP2C19-inhibitor: | 0.175 | CYP2C19-substrate: | 0.097 |
CYP2C9-inhibitor: | 0.103 | CYP2C9-substrate: | 0.339 |
CYP2D6-inhibitor: | 0.225 | CYP2D6-substrate: | 0.48 |
CYP3A4-inhibitor: | 0.721 | CYP3A4-substrate: | 0.259 |
Clearance (CL): | 1.751 | Half-life (T1/2): | 0.294 |
hERG Blockers: | 0.058 | Human Hepatotoxicity (H-HT): | 0.14 |
Drug-inuced Liver Injury (DILI): | 0.379 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.773 | Maximum Recommended Daily Dose: | 0.684 |
Skin Sensitization: | 0.05 | Carcinogencity: | 0.058 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002631 | 0.696 | D0W7WC | 0.270 | ||||
ENC004929 | 0.663 | D01PZD | 0.253 | ||||
ENC005569 | 0.595 | D05MQK | 0.246 | ||||
ENC001957 | 0.595 | D0H5MB | 0.246 | ||||
ENC004930 | 0.570 | D0U7GP | 0.243 | ||||
ENC003796 | 0.528 | D01JGV | 0.243 | ||||
ENC002895 | 0.522 | D03GET | 0.238 | ||||
ENC002717 | 0.495 | D05EJG | 0.236 | ||||
ENC004926 | 0.490 | D05EPM | 0.236 | ||||
ENC002068 | 0.485 | D0U7GK | 0.235 |